.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,979,694

« Back to Dashboard

Details for Patent: 6,979,694

Title: Cyclic protein tyrosine kinase inhibitors
Abstract:Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
Inventor(s): Das; Jagabandhu (Mercerville, NJ), Padmanabha; Ramesh (Hamden, CT), Chen; Ping (Belle Mead, NJ), Norris; Derek J. (Trenton, NJ), Doweyko; Arthur M. P. (Long Valley, NJ), Barrish; Joel C. (Holland, PA), Wityak; John (Robbinsville, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Filing Date:Mar 03, 2003
Application Number:10/378,372
Claims:1. A compound of formula I or salt thereof ##STR622##

where Q is thiazole optionally substituted with R.sub.1 ; Z is a single bond; X.sub.1 and X.sub.2 together form .dbd.O; R.sub.1 is (1) hydrogen or R.sub.6,

where R.sub.6 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, or aralkyl, each of which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and one or more groups Z.sub.3 ; (2) --OH or --OR.sub.6 ; (3) --SH or --SR.sub.6 ; (4) --C(O).sub.2 H, --C(O).sub.q R.sub.6, or --O--C(O).sub.q R.sub.6, where q is 1 or 2; (5) --SO.sub.3 H or --S(O).sub.q R.sub.6 ; (6) halo; (7) cyano; (8) nitro; (9) -Z.sub.4 -NR.sub.7 R.sub.8 ; (10) -Z.sub.4 -N(R.sub.9)-Z.sub.5 -NR.sub.10 R.sub.11 ; (11) -Z.sub.4 -N(R.sub.12)-Z.sub.5 -R.sub.6 ; (12) --P(O)(OR.sub.6).sub.2 ; R.sub.2 is hydrogen, R.sub.6, -Z.sub.4 -R.sub.6 or -Z.sub.13 -NR.sub.7 R.sub.8 ; R.sub.3 is -Z.sub.4 -R.sub.6 where Z.sub.4 is --SO.sub.2 -, --C(O)--, or --C(O)O--; R.sub.4 and R.sub.5 (1) are each independently hydrogen or R.sub.6 ; (2) -Z.sub.4 -N(R.sub.9)-Z.sub.5 -NR.sub.10 R.sub.11 ; (3) --N(R.sub.9)Z.sub.4 R.sub.6 ; or (4) together with the nitrogen atom to which they are attached complete a 3- to 8-membered saturated or unsaturated heterocyclic ring which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3, which heterocyclic ring may optionally have fused to it a benzene ring itself unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; R.sub.7, R.sub.8, R.sub.9, R.sub.10, R.sub.11 and R.sub.12 (1) are each independently hydrogen or R.sub.6 ; (2) R.sub.7 and R.sub.8 may together be alkylene, alkenylene or heteroalkyl, completing a 3- to 8-membered saturated or unsaturated ring with the nitrogen atom to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; or (3) any two of R.sub.9, R.sub.10 and R.sub.11 may together be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the nitrogen atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; R.sub.13 is (1) cyano; (2) nitro; (3) --NH.sub.2 ; (4) --NHOalkyl; (5) --OH; (6) --NHOaryl; (7) --NHCOOalkyl; (8) --NHCOOaryl; (9) --NHSO.sub.2 alkyl; (10) --NHSO.sub.2 aryl; (11) aryl; (12) heteroaryl; (13) --Oalkyl; or (14) --Oaryl; R.sub.14 is (1) --NO.sub.2 ; (2) --COOalkyl; or (3) --COOaryl; R.sub.15 is (1) hydrogen; (2) alkyl; (3) aryl; (4) arylalkyl; or (5) cycloalkyl; Z.sub.1, Z.sub.2 and Z.sub.3 are each independently (1) hydrogen or Z.sub.6, where Z.sub.6 is (i) alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aralkyl, alkylaryl, cycloalkylaryl, heterocyclo, or heterocycloalkyl; (ii) a group (i) which is itself substituted by one or more of the same or different groups (i); or (iii) a group (i) or (ii) which is substituted by one or more of the following groups (2) to (16) of the definition of Z.sub.1, Z.sub.2 and Z.sub.3 ; (2) --OH or --OZ.sub.6 ; (3) --SH or --SZ.sub.6 ; (4) --C(O).sub.q H, --C(O).sub.q Z.sub.6, or --O--C(O).sub.q Z.sub.6 ; (5) --SO.sub.3 H, --S(O).sub.q Z.sub.6 ; or S(O).sub.q N(Z.sub.9)Z.sub.6 ; (6) halo; (7) cyano; (8) nitro; (9) -Z.sub.4 -NZ.sub.7 Z.sub.8 ; (10) -Z.sub.4 -N(Z.sub.9)-Z.sub.5 -NZ.sub.7 Z.sub.8 ; (11) -Z.sub.4 -N(Z.sub.10)-Z.sub.5 -Z.sub.6 ; (12) -Z.sub.4 -N(Z.sub.10)-Z.sub.5 -H; (13) oxo; (14) --O--C(O)-Z.sub.6 ; (15) any two of Z.sub.1, Z.sub.2, and Z.sub.3 may together be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the atoms to which they are attached; or (16) any two of Z.sub.1, Z.sub.2, and Z.sub.3 may together be --O--(CH.sub.2).sub.r --O--, where r is 1 to 5, completing a 4- to 8-membered ring together with the atoms to which they are attached; Z.sub.4 and Z.sub.5 are each independently (1) a single bond; (2) -Z.sub.11 -S(O).sub.q -Z.sub.12 -; (3) -Z.sub.11 -C(O)-Z.sub.12 -; (4) -Z.sub.11 -C(S)-Z.sub.12 -; (5) -Z.sub.11 -O-Z.sub.12 -; (6) -Z.sub.11 -S-Z.sub.12 -; (7) -Z.sub.11 -O--C(O)-Z.sub.12 -; or (8) -Z.sub.11 -C(O)--O-Z.sub.12 -; Z.sub.7, Z.sub.8, Z.sub.9 and Z.sub.10 (1) are each independently hydrogen or Z.sub.6 ; (2) Z.sub.7 and Z.sub.8, or Z.sub.6 and Z.sub.10, may together be alkylene or alkenylene, completing a 3- to 8-membered saturated or unsaturated ring together with the atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; or (3) Z.sub.7 or Z.sub.8, together with Z.sub.9, may be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the nitrogen atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; Z.sub.11 and Z.sub.12 are each independently (1) a single bond; (2) alkylene; (3) alkenylene; or (4) alkynylene; and Z.sub.13 is (1) a single bond; (2) -Z.sub.11 -S(O).sub.q -Z.sub.12 -; (3) -Z.sub.11 -C(O)-Z.sub.12 -; (4) -Z.sub.11 -C(S)-Z.sub.12 -; (5) -Z.sub.11 -O-Z.sub.12 -; (6) -Z.sub.11 -S-Z.sub.12 -; (7) -Z.sub.11 -O--C(O)-Z.sub.12 -; (8) -Z.sub.11 -C(O)--O-Z.sub.12 -; (9) --C(NR.sub.13)--; (10) --C(CHR.sub.14)--; or (11) --C(C(R.sub.14).sub.2)- provided said compound is other than a compound of formula (i) ##STR623## where R.sub.1a is alkyl or --C(O)NHNH.sub.2 ; R.sub.2a and R.sub.3a are independently hydrogen, alkyl, --C(O)-(alk); and R.sub.4a is hydrogen and R.sub.5a is aryl, alkyl-substituted aryl, halo-substituted aryl, aralkyl, cycloalkyl or amino; Or R.sub.4a is alkyl and R.sub.5a is alkyl or aryl; Or R.sub.4a and R.sub.5a together with the nitrogen atom to which they are bonded together from morpholino.

2. A compound of claim 1 wherein R.sub.1 is hydrogen, halo, alkyl, aryl, alkoxy, alkoxycarbonyl, or aryloxycarbonyl.

3. A compound of claim 2 wherein R.sub.1 is hydrogen.

4. A compound of claim 2 wherein R.sub.2 is hydrogen.

5. A compound of claim 2 wherein R.sub.4 is hydrogen.

6. A compound of claim 2 wherein R.sub.5 is an aryl group which is substituted with Z.sub.1, Z.sub.2 and one or more groups Z.sub.3.

7. A compound of claim 2 wherein R.sub.1 is hydrogen or alkyl, R.sub.2 and R.sub.4 are independently hydrogen or alkyl, and R.sub.5 is aryl which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and one or more groups Z.sub.3.

8. A compound of claim 7 wherein R.sub.5 is aryl which is unsubstituted or independently substituted with one or more alkyl or halo.

9. A compound of formula II or salt thereof ##STR624## where n is 1; X.sub.3 is oxygen; A is nitrogen; B is sulfur R.sub.1 is (1) hydrogen or R.sub.6, where R.sub.6 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, or aralkyl, each of which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and one or more groups Z.sub.3 ; (2) --OH or --OR.sub.6 ; (3) --SH or --SR.sub.6 ; (4) --C(O).sub.2 H, --C(O).sub.q R.sub.6, or --OC(O).sub.q R.sub.6, where q is 1 or 2; (5) --SO.sub.3 H or --S(O).sub.q R.sub.6 ; (6) halo; (7) cyano; (8) nitro; (9) -Z.sub.4 -NR.sub.7 R.sub.8 ; (10) -Z.sub.4 -N(R.sub.9)-Z.sub.5 -NR.sub.10 R.sub.11 ; (11) -Z.sub.4 -N(R.sub.12)-Z.sub.5 -R.sub.6 ; (12) --P(O)(OR.sub.6).sub.2 ; R.sub.2 is hydrogen, R.sub.6, -Z.sub.4 -R.sub.6 or -Z.sub.13 -NR.sub.7 R.sub.8 ; R.sub.3 is -Z.sub.4 -R.sub.6 where Z.sub.4 is --SO.sub.2 -, --C(O)--, or --C(O)O--; R.sub.4 and R.sub.5 (1) are each independently hydrogen or R.sub.6 ; (2) -Z.sub.4 -N(R.sub.9)-Z.sub.5 -NR.sub.10 R.sub.11 ; (3) --N(R.sub.9)Z.sub.4 R.sub.6 ; or (4) together with the nitrogen atom to which they are attached complete a 3- to 8-membered saturated or unsaturated heterocyclic ring which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3, which heterocyclic ring may optionally have fused to it a benzene ring itself unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; R.sub.7, R.sub.8, R.sub.9, R.sub.10, R.sub.11 and R.sub.12 (1) are each independently hydrogen or R.sub.6 ; (2) R.sub.7 and R.sub.8 may together be alkylene, alkenylene or heteroalkyl, completing a 3- to 8-membered saturated or unsaturated ring with the nitrogen atom to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; or (3) any two of R.sub.9, R.sub.10 and R.sub.11 may together be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the nitrogen atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; R.sub.13 is (1) cyano, (2) nitro; (3) --NH.sub.2 ; (4) --NHOalkyl; (5) --OH; (6) --NHOaryl; (7) --NHCOOalkyl; (8) --NHCOOaryl; (9) --NHSO.sub.2 alkyl; (10) --NHSO.sub.2 aryl; (11) aryl; (12) heteroaryl; (13) --Oalkyl; or (14) --Oaryl; R.sub.14 is (1) --NO.sub.2 ; (2) --COOalkyl; or (3) --COOaryl; R.sub.15 is (1) hydrogen; (2) alkyl; (3) aryl; (4) arylalkyl; or (5) cycloalkyl; Z.sub.1, Z.sub.2 and Z.sub.3 are each independently (1) hydrogen or Z.sub.6, where Z.sub.6 is (i) alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aralkyl, alkylaryl, cycloalkylaryl, heterocyclo, or heterocycloalkyl, (ii) a group (i) which is itself substituted by one or more of the same or different groups (i); or (iii) a group (i) or (ii) which is substituted by one or more of the following groups (2) to (16) of the definition of Z.sub.2, Z.sub.2 and Z.sub.3 ; (2) --OH or --OZ.sub.6 ; (3) --SH or --SZ.sub.6 ; (4) --C(O).sub.q H, --C(O).sub.q Z.sub.6, or --O--C(O).sub.q Z.sub.6 ; (5) --SO.sub.3 H, --S(O).sub.q Z.sub.6 ; or S(O).sub.q N(Z.sub.9)Z.sub.6 ; (6) halo; (7) cyano; (8) nitro; (9) -Z.sub.4 --NZ.sub.7 Z.sub.8 ; (10) -Z.sub.4 -N(Z.sub.9)-Z.sub.5 -NZ.sub.7 Z.sub.8 ; (11) -Z.sub.4 -N(Z.sub.10)-Z.sub.5 -Z.sub.6 ; (12) -Z.sub.6 -N(Z.sub.10)-Z.sub.5 -H; (13) oxo; (14) --O--C(O)-Z.sub.6 ; (15) any two of Z.sub.1, Z.sub.2, and Z.sub.3 may together be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the atoms to which they are attached; or (16) any two of Z.sub.1, Z.sub.2, and Z.sub.3 may together be --O--(CH2).sub.r --O-- where r is 1 to 5, completing a 4-to 8-membered ring together with the atoms to which they are attached; Z.sub.4 and Z.sub.5 are each independently (1) a single bond; (2) -Z.sub.11 -S(O).sub.q -Z.sub.12 -; (3) -Z.sub.11 -C(O)-Z.sub.12 -; (4) -Z.sub.11 -C(S)-Z.sub.12 -; (5) -Z.sub.11 -O-Z.sub.12 -; (6) -Z.sub.11 -S-Z.sub.12 -; (7) -Z.sub.11 -O--C(O)-Z.sub.12 -; or (8) -Z.sub.11 -C(O)--O-Z.sub.12 -; Z.sub.7, Z.sub.8, Z.sub.9 and Z.sub.10 (1) are each independently hydrogen or Z.sub.6 ; (2) Z.sub.7 and Z.sub.8, or Z.sub.6 and Z.sub.10, may together be alkylene or alkenylene, completing a 3- to 8-membered saturated or unsaturated ring together with the atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; or (3) Z.sub.7 or Z.sub.8, together with Z.sub.9, may be alkylene or alkenylene completing a 3- to 8-membered saturated or unsaturated ring together with the nitrogen atoms to which they are attached, which ring is unsubstituted or substituted with Z.sub.1, Z.sub.2 and Z.sub.3 ; Z.sub.11 and Z.sub.12 are each independently (1) a single bond; (2) alkylene; (3) alkenylene; or (4) alkynylene; and Z.sub.13 is (1) a single bond; (2) -Z.sub.11 -S(O).sub.q -Z.sub.12 -; (3) -Z.sub.11 -C(O)-Z.sub.12 -; (4) -Z.sub.11 -C(S)-Z.sub.12 -; (5) -Z.sub.11 -O-Z.sub.12 -; (6) -Z.sub.11 -S-Z.sub.12 -; (7) -Z.sub.11 -O--C(O)-Z.sub.12 -; (8) -Z.sub.11 -C(O)--O-Z.sub.12 -; (9) --C(NR.sub.13)--; (10) --C(CHR.sub.14)--; or (11) --C(C(R.sub.14).sub.2)--, provided said compound is other than a compound of formula (i) ##STR625##

where R.sub.1a is alkyl or --C(O)NHNH.sub.2 ; R.sub.2a and R.sub.3a are independently hydrogen, alkyl, --C(O)-(alk); and R.sub.4a is hydrogen and R.sub.5a is aryl, alkyl-substituted aryl, halo-substituted aryl, aralkyl, cycloalkyl or amino; Or R.sub.4a is alkyl and R.sub.5a is alkyl or aryl; Or R.sub.4a and R.sub.5a together with the nitrogen atom to which they are bonded together from morpholino.

10. A compound of claim 9 wherein R.sub.1 is hydrogen or alkyl, R.sub.2 and R.sub.4 are independently hydrogen or alkyl, and R.sub.5 is aryl which is unsubstituted or substituted with Z.sub.1, Z.sub.2 and one or more groups Z.sub.3.

11. A compound of claim 10 wherein R.sub.5 is axyl which is unsubstituted or independently substituted with one or more alkyl or halo.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc